- AGEN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $14.5 million.
- AGEN has traded 511,376 shares today.
- AGEN is down 3.8% today.
- AGEN was up 7.3% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in AGEN with the Ticky from Trade-Ideas. See the FREE profile for AGEN NOW at Trade-Ideas More details on AGEN: Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. Currently there are 3 analysts that rate Agenus a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Agenus has been 1.4 million shares per day over the past 30 days. Agenus has a market cap of $544.7 million and is part of the health care sector and drugs industry. The stock has a beta of 0.16 and a short float of 11% with 3.65 days to cover. Shares are up 106% year-to-date as of the close of trading on Friday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.